Compounds > rebeccamycin
Page last updated: 2024-08-25

rebeccamycin and Disease Exacerbation

rebeccamycin has been researched along with Disease Exacerbation in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burstein, HJ; Clarke, K; Dumadag, L; Gelman, R; Ivy, P; Overmoyer, B; Savoie, J; Silverman, P; Winer, EP; Younger, J1

Trials

1 trial(s) available for rebeccamycin and Disease Exacerbation

ArticleYear
Rebeccamycin analog for refractory breast cancer: a randomized phase II trial of dosing schedules.
    Investigational new drugs, 2007, Volume: 25, Issue:2

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Blood Cell Count; Breast Neoplasms; Carbazoles; Disease Progression; Drug Resistance, Neoplasm; Endpoint Determination; Female; Humans; Indoles; Middle Aged

2007

Other Studies

1 other study(ies) available for rebeccamycin and Disease Exacerbation

ArticleYear
BMS and Exelixis target tumor suppression pathways.
    Expert review of anticancer therapy, 2001, Volume: 1, Issue:2

    Topics: Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Carbazoles; Cell Death; Clinical Trials as Topic; Disease Progression; Drug Design; Drug Industry; Genes, Tumor Suppressor; Humans; Indoles; Neoplasms

2001